Showing results (1121-1130 of 1,200) with videos related to

Sort By:
Pageof 120
The Journal of Pathology|October 3, 2024
The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformationSamuel Backman, Johan Botling, Helena Nord, et al.
British Journal of Haematology|May 29, 2024
Decreased spermatogonial numbers in boys with severe haematological diseasesAtte K Lahtinen, Miriam Funke, Claudia Krallmann, et al.
The American Journal of Medicine|December 4, 2018
Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary ArteriesDaniella Nero, Stefan Agewall, Maria Daniel, et al.
The American Journal of Medicine|June 4, 2018
Prevalence of Anxiety and Depression Symptoms in Patients with Myocardial Infarction with Non-Obstructive Coronary ArteriesMaria Daniel, Stefan Agewall, Felix Berglund, et al.
Haematologica|September 11, 2016
Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosisAmanda J Walne, Laura Collopy, Shirleny Cardoso, et al.
Advances in Therapy|August 5, 2026
Treatment Strategies in Incident and Recurrent Hyperkalemia: Insights from the TRACK StudyPietro Manuel Ferraro, Nitin Shivappa, Ameet Bakhai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2025
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary AldosteronismDaniel Gillett, Russell Senanayake, James MacFarlane, et al.
Frontiers in Pediatrics|April 1, 2022
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-NFredrik Sundquist, Kleopatra Georgantzi, Kirsten Brunsvig Jarvis, et al.
The Lancet. Oncology|October 30, 2025
Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in SwedenCecilia O Ladjevardi, Ylva Naeser, Ulf Dyrke, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2005
Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related proteinOlof H Sundin, Gregory S Leppert, Eduardo D Silva, et al.
Pageof 120